Big Pharma — Naltrexone

Naltrexone use decreases the risk of hospitalization in persons with alcohol use disorder

decreases hospitalization Naltrexone risk

Naltrexone use decreases the risk of hospitalization in persons with alcohol use disorder

Naltrexone use decreases the risk of hospitalization in persons with alcohol use disorder Naltrexone, used either alone or together with disulfiram or acamprosate, is associated with a decreased risk of hospitalization due to alcohol use disorder (AUD) when compared with non-use of AUD drugs, a new register-based study shows. The same associations were noticed for hospitalization due to any cause. Disulfiram use and polytherapy with two or more drugs indicated for AUD was associated with a decreased risk of hospitalization due to alcohol-related somatic causes. None of the studied medications were associated with mortality or work disability (sickness absence or...

Leer más →